Revvity

📍 Waltham, United States🗓 Founded 2023👥 3,024 employees💰 Last funded Oct 2017
Biotechnology Research🌐 revvity.com
Website LinkedIn
At Revvity, “impossible” is inspiration, and ""cant be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Revvity?
Revvity has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Revvity last raise funding?
The most recent investment in Revvity recorded on gritt.io was in October 2017.
When was Revvity founded?
Revvity was founded in 2023.
What industry is Revvity in?
Revvity operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Revvity based?
Revvity is headquartered in Waltham, United States.